Dynavax Reports Third Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Dynavax Technologies (DVAX) PT Raised to $30 at Cowen
November 5, 2021 6:45 AM EDTCowen analyst Phil Nadeau raised the price target on Dynavax Technologies (NASDAQ: DVAX) to $30.00 (from $20.00) while maintaining an Outperform rating.
The analyst commented, "DVAX reported Q3 Heplisav rev. of $22.7MM, above consensus ($15MM) as share at targeted accounts increased to... More
Dynavax (DVAX) Reports Q3 Loss of $0.24/sh
November 4, 2021 5:31 PM EDTDynavax (NASDAQ: DVAX) reported Q3 EPS of ($0.24), versus ($0.15) reported last year. Revenue for the quarter came in at $108.3 million, versus $13.41 million reported last year.
For earnings history and earnings-related data on Dynavax (DVAX) click here.
... More